Akoya Biosciences Inc (AKYA)
4.00
-0.13
(-3.15%)
USD |
NASDAQ |
Apr 15, 16:00
4.02
+0.02
(+0.50%)
After-Hours: 20:00
Akoya Biosciences Enterprise Value: 188.69M for April 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 15, 2024 | 188.69M |
| April 12, 2024 | 195.08M |
| April 11, 2024 | 203.43M |
| April 10, 2024 | 203.43M |
| April 09, 2024 | 206.87M |
| April 08, 2024 | 199.50M |
| April 05, 2024 | 206.38M |
| April 04, 2024 | 199.50M |
| April 03, 2024 | 204.91M |
| April 02, 2024 | 208.84M |
| April 01, 2024 | 216.21M |
| March 28, 2024 | 222.60M |
| March 27, 2024 | 224.56M |
| March 26, 2024 | 219.65M |
| March 25, 2024 | 233.90M |
| March 22, 2024 | 227.51M |
| March 21, 2024 | 237.34M |
| March 20, 2024 | 239.80M |
| March 19, 2024 | 239.31M |
| March 18, 2024 | 234.88M |
| March 15, 2024 | 233.41M |
| March 14, 2024 | 230.95M |
| March 13, 2024 | 232.92M |
| March 12, 2024 | 230.95M |
| March 11, 2024 | 230.46M |
| Date | Value |
|---|---|
| March 08, 2024 | 237.83M |
| March 07, 2024 | 226.04M |
| March 06, 2024 | 235.87M |
| March 05, 2024 | 242.75M |
| March 04, 2024 | 285.99M |
| March 01, 2024 | 288.45M |
| February 29, 2024 | 274.20M |
| February 28, 2024 | 270.27M |
| February 27, 2024 | 279.11M |
| February 26, 2024 | 258.35M |
| February 23, 2024 | 261.79M |
| February 22, 2024 | 254.91M |
| February 21, 2024 | 250.98M |
| February 20, 2024 | 268.66M |
| February 16, 2024 | 284.87M |
| February 15, 2024 | 277.99M |
| February 14, 2024 | 262.28M |
| February 13, 2024 | 256.87M |
| February 12, 2024 | 282.41M |
| February 09, 2024 | 289.78M |
| February 08, 2024 | 283.40M |
| February 07, 2024 | 285.85M |
| February 06, 2024 | 284.87M |
| February 05, 2024 | 264.73M |
| February 02, 2024 | 272.59M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
138.79M
Minimum
Oct 27 2023
953.89M
Maximum
Apr 16 2021
377.67M
Average
361.04M
Median
Apr 18 2022
Enterprise Value Benchmarks
| Bruker Corp | 12.64B |
| Azenta Inc | 2.000B |
| Harvard Bioscience Inc | 224.97M |
| Bionano Genomics Inc | 20.79M |
| Singular Genomics Systems Inc | -134.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.80M |
| Revenue (Quarterly) | 26.49M |
| Total Expenses (Quarterly) | 35.31M |
| EPS Diluted (Quarterly) | -0.20 |
| Gross Profit Margin (Quarterly) | 62.75% |
| Profit Margin (Quarterly) | -40.78% |
| Earnings Yield | -36.50% |
| Normalized Earnings Yield | -35.71 |